These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19105905)

  • 1. A novel surface modification using tissue factor reconstituted in phospholipid vesicles for the activation of blood coagulation.
    Svedhem S; Wikström A; Deinum J; Kasemo B; Hansson K
    J Biomater Sci Polym Ed; 2009; 20(1):133-40. PubMed ID: 19105905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.
    Bogdanov VY; Balasubramanian V; Hathcock J; Vele O; Lieb M; Nemerson Y
    Nat Med; 2003 Apr; 9(4):458-62. PubMed ID: 12652293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 4. Probing the interaction of coagulation factors with phospholipid vesicle surfaces by surface plasma resonance.
    Wikström A; Deinum J
    Anal Biochem; 2007 Mar; 362(1):98-107. PubMed ID: 17239338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: the use of recombinant human tissue factor as an example.
    Jones LS; Cipolla D; Liu J; Shire SJ; Randolph TW
    Pharm Res; 1999 Jun; 16(6):808-12. PubMed ID: 10397598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model.
    Tseng PY; Rele SS; Sun XL; Chaikof EL
    Biomaterials; 2006 Apr; 27(12):2637-50. PubMed ID: 16376423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and characterization of heparin functionalized membrane-mimetic assemblies.
    Tseng PY; Rele SM; Sun XL; Chaikof EL
    Biomaterials; 2006 Apr; 27(12):2627-36. PubMed ID: 16368135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
    He S; Zhu K; Skeppholm M; Vedin J; Svensson J; Egberg N; Blombäck M; Wallen H
    Thromb Haemost; 2007 Oct; 98(4):871-82. PubMed ID: 17938814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and efficient incorporation of tissue factor into liposomes.
    Smith SA; Morrissey JH
    J Thromb Haemost; 2004 Jul; 2(7):1155-62. PubMed ID: 15219199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis.
    Hong J; Andersson J; Ekdahl KN; Elgue G; Axén N; Larsson R; Nilsson B
    Thromb Haemost; 1999 Jul; 82(1):58-64. PubMed ID: 10456455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation on biomaterials requires the combination of distinct activation processes.
    Sperling C; Fischer M; Maitz MF; Werner C
    Biomaterials; 2009 Sep; 30(27):4447-56. PubMed ID: 19535136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
    John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
    Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Material-specific thrombin generation following contact between metal surfaces and whole blood.
    Hong J; Azens A; Ekdahl KN; Granqvist CG; Nilsson B
    Biomaterials; 2005 Apr; 26(12):1397-403. PubMed ID: 15482827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model.
    Andersson J; Bexborn F; Klinth J; Nilsson B; Ekdahl KN
    J Biomed Mater Res A; 2006 Jan; 76(1):25-34. PubMed ID: 16250010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to shape emerges in a complex biochemical network and its simple chemical analogue.
    Kastrup CJ; Shen F; Ismagilov RF
    Angew Chem Int Ed Engl; 2007; 46(20):3660-2. PubMed ID: 17407119
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation interventions in experimental human endotoxemia.
    Mayr FB; Jilma B
    Transl Res; 2006 Nov; 148(5):263-71. PubMed ID: 17145572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation by means of various adsorbents. (Contribution to the mechanism of contact activation of the blood coagulation process)].
    Tóth AM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):80-8. PubMed ID: 88393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system.
    Tsuda T; Yoshimura H; Hamasaki N
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):465-9. PubMed ID: 16905950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood plasma coagulation studied by surface plasmon resonance.
    Vikinge TP; Hansson KM; Benesch J; Johansen K; Rånby M; Lindahl TL; Liedberg B; Lundstöm I; Tengvall P
    J Biomed Opt; 2000 Jan; 5(1):51-5. PubMed ID: 10938766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.